Clinical Trials Browser

Unknown × nimotuzumab × CNS × Clear all

NCT03620032 2023-12-06

DIPG

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

NCT04833205 2021-04-20

Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer

Phase 2 Unknown

Lung Neoplasms, Meningeal Carcinomatosis